AltPep
AltPep develops early detection tools and disease-modifying treatments for amyloid diseases, including neurodegenerative conditions and type 2 diabetes, by targeting toxic soluble oligomers. Its lead program focuses on identifying Alzheimer’s disease before symptoms appear and neutralizing the associated toxic oligomers. The organization aims to enable early screening and preventive intervention for these diseases.
Facts
- HQ
- Seattle, WA
- Sectors
- Biotechnology
- Founded
- 2019
- Type
- Corporation Seattle business license
- Employees
- 32
- Registered name
- AltPep Corporation Seattle business license
- Stage
- Series B
- Members see funding amounts. .
Is this your organization? Claim it
Pictory Wins Startup of the Year at 2024 GeekWire Awards in Seattle Featuring Live Music and Surprise Guests
The 2024 GeekWire Awards in Seattle celebrated Pacific Northwest tech with winners like Pictory, live music, and surprise guests, hosted at Showbox SoDo. The event featured sponsors such as Astound Business Solutions and included networking, entertainment, and a nostalgic tech theme.
University of Washington’s CoMotion Innovation Arm Moving to Condon Hall Near Startup Hall in 2023
The University of Washington's innovation arm, CoMotion, will relocate from the Blume building to Condon Hall near Startup Hall later this year, expanding its space and event capabilities. Startup Hall is part of the Portage Bay Crossing neighborhood, which aims to foster research, education, and entrepreneurship.
AltPep Raises $52.9M to Advance Early Detection and Treatments for Alzheimer’s and Parkinson’s Diseases
AltPep, a University of Washington spinout developing tests and treatments for Alzheimer’s and Parkinson’s, raised $52.9 million in Series B funding to advance clinical trials and regulatory approval for its early detection blood test. The company targets toxic oligomers linked to Alzheimer’s and a related protein in Parkinson’s, aiming to enable early screening and preventive treatment.
People
-
Valerie Daggett Executive Officer, Director, Promoter, Founder and CEO
Online
Questions about AltPep
What is AltPep?
AltPep is a startup based in Seattle, WA that develops early detection tools and disease-modifying treatments for amyloid diseases, including neurodegenerative conditions and type 2 diabetes, by targeting toxic soluble oligomers.
What has AltPep been in the news for?
GeekWire reported in June 2023 on AltPep’s work to advance early detection and treatments for Alzheimer’s and Parkinson’s diseases.
Who are the people behind AltPep?
Valerie Daggett is AltPep’s founder and CEO, and is also listed as executive officer and promoter.
Who invested in AltPep, and how much has it raised?
Members of Seattle Flow see AltPep's funding rounds, amounts and investors on its Funding tab. Joining is free.
Where is AltPep based?
AltPep is based in Seattle, WA.
When was AltPep founded?
AltPep was founded in 2019.